Date posted
Jan
5
Innovation doesn't happen in isolation. It happens when entrepreneurs, researchers, investors, and industry leaders come together to share ideas,...
Read PostNews
Stay up-to-date on the latest industry, member, & policy related news.
Share your News
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
Advocacy
Advocacy :
Federal Advocacy
Advocacy :
State Advocacy
Association Updates
BioConnections® Jobs
Event
Event :
Industry Event
Event :
MichBio Advocacy Events
Event :
MichBio Networking Event
Event :
MichBio Signature Event
Event :
MichBio Webinar
Event :
Partner Event
Member Feature
News
News :
Industry News
News :
Member News
News :
MichBio News/Statement
News :
Michigan News
Date posted
Dec
23
The Winter 2025 issue of BioMatters® is now available online, showcasing the people, companies, and ideas driving Michigan’s biosciences...
Read Post
Date posted
Dec
22
In late December 2025, Congress completed action on the FY 2026 National Defense Authorization Act (NDAA)and with it, the...
Read Post
Date posted
Dec
22
Access to capital remains one of the most persistent challenges facing early-stage life sciences companies. On December 11, the U.S. House of...
Read Post
Date posted
Dec
22
Mergers and acquisitions (M&A) are a defining feature of the global life sciences industry. While often discussed in terms of market...
Read Post
Date posted
Dec
22
In October, MichBio was awarded a competitively selected Michigan Innovation Fund (MIF) grant to launch MI BioTalent Connect, a new statewide...
Read Post
Date posted
Dec
22
The U.S. Food and Drug Administration (FDA) has taken a noteworthy step toward modernizing how it collaborates with innovative technology...
Read Post
Date posted
Dec
22
In 2025, MichBio continued to advance its core mission: strengthening Michigan’s life sciences ecosystem by connecting people, shaping...
Read Post
Date posted
Dec
15
Talent continues to be one of the biggest challenges facing Michigan’s life sciences industry—and one of the greatest opportunities for...
Read Post
Date posted
Dec
8
The Advanced Research Projects Agency for Health (ARPA-H) – Health & Human Service (HHS)’s “high-risk,...
Read Post
Date posted
Dec
8
After the FDA’s Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) authority lapsed at the end of 2024, patient groups and drug...
Read Post
Date posted
Dec
8
A major bipartisan push to overhaul pharmacy benefit managers (PBMs) is back on the Senate agenda. On Dec. 4, Senate Finance Committee...
Read Post